image: The scientific board will address questions designed to stimulate discussion and provide comprehensive exploration during Targeting EVs 2024, October 17-18 in Malta.
Credit: World Mitochondria Society & International Society of Microbiota
Malta, July 5, 2024 - The program for the highly anticipated world conference on Targeting Extracellular Vesicles (EVs) has been released. The event, organized by the World Mitochondria Society and the International Society of Microbiota, is scheduled to take place on October 17-18, 2024, at the Corinthia Palace in Malta.
Exploring Strategic Questions at Targeting EVs 2024
The Targeting EVs 2024 conference promises to explore the multifaceted roles of EVs, with a special focus on their interactions with mitochondria and microbiota.
The scientific board has curated a series of stimulating questions to foster comprehensive exploration and strategic discussions.
"Our aim is to discuss and try to answer many strategic questions that remain unresolved", stated M. Edeas, Institut Cochin, INSERM U1016, Université de Paris, France, member of the scientific committee and founder of the World Mitochondria Society.
Key topics to be debated by speakers include:
Non-Standardization of EVs and Exosomes:
- What are the main challenges preventing the standardization of EVs and exosomes in research and clinical applications?
- What steps are being taken by the scientific community to develop standardized protocols for EV and exosome research?
- How do the physicochemical properties of EVs and exosomes contribute to the difficulty in establishing standard practices?
Targeting EVs and Exosomes to Specific Organs and Tissues:
- What are the current methods used to target EVs and exosomes to specific organs or tissues?
- How can surface modifications on EVs enhance their targeting efficiency?
- What role do ligands and receptors play in the targeted delivery of EVs and exosomes?
- How does the microenvironment of specific tissues influence the uptake of EVs and exosomes?
- What are the potential therapeutic benefits of precisely targeting EVs and exosomes to tumors?
- How can EVs be used as vehicles for different cargo and drugs?
Using EVs and Exosomes as Biomarkers:
- Why is using EVs and exosomes as biomarkers still considered far from reality?
- What are the key challenges in isolating and identifying specific EVs and exosomes as disease markers?
- How can advances in high-throughput technologies improve the feasibility of using EVs and exosomes as biomarkers?
- What are the potential advantages of using EVs and exosomes over traditional biomarkers?
- How can multi-omics approaches enhance the reliability of EVs and exosomes as diagnostic tools?
Mitochondria & Microbiota: Crucial Impact
- How do EVs contribute to the optimization of mitochondrial function through protein and genetic material transfer?
- What are the mechanisms by which EVs can spread damaged mitochondrial components, and how does this affect disease progression?
- In what ways can targeted drug delivery via EVs improve mitochondrial-related therapies?
- How do microbiota-derived EVs facilitate communication between microbial communities and host cells?
- What potential biomarkers can be identified from microbiota-derived EVs for immune modulation?
- How can understanding microbiota-derived EVs lead to new therapeutic strategies for managing microbiota-related diseases?
Join us in Malta to engage in these groundbreaking discussions and contribute to the advancement of EV research and applications.
For more information and to view the full program, please visit [conference website link].
About the World Mitochondria Society:
The World Mitochondria Society is dedicated to advancing the understanding of mitochondria's role in health and disease, fostering collaboration among scientists, and promoting the translation of research into clinical applications.
About the International Society of Microbiota:
The International Society of Microbiota aims to bring together researchers and clinicians to explore the complex roles of microbiota in health and disease, fostering innovation and collaboration in microbiota research.